Preview

Современная ревматология

Расширенный поиск

Современные возможности терапии псориатического артрита

https://doi.org/10.14412/1996-7012-2008-468

Полный текст:

Аннотация

Представлены современные данные о распространенности, иммунопатогенезе, основных клинических проявлениях псориатического артрита (ПсА). На основании результатов рандомизированных клинических исследований дан сравнительный анализ традиционных и современных методов терапии ПсА биологическими агентами.

Литература

1. <div><p>Gladman D. Effectiveness of Psoriatic Arthritis Therapies. Semin Arthr Rheum 2003; 33(1): 29-37.</p><p>Brand J., Braun J. Anti-TNF-а agents in the treatment of Psoriatic Arthritis. Expert Opin Biol Ther. 2006; 6(2):99-107.</p><p>Gladman D., Shuckett R., Russel M. et al. Psoriatic Arthritis - clinical and laboratory analysis of 220 patients. Q J Med 1987; 62(238): 127-141.</p><p>Kane D., Stafford L., Bresnihan B., FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinical experience. Rheumatology (Oxford) 2003; 42(12): 1460-8.</p><p>Kavanaugh A., Ritchlin C. Group for Research and Assesment of Psoriasis and Psoriatic Arthritis (GRAPPA): Systematic Review of Treatments of Psoriatic Arthritis. J Rheumatology 2006; 33 (7): 1417-56.</p><p>Soriano E., McHugh N. Therapies for peripheral joint disease in psoriatic arthritis. A systematic Review. J Rheum 2006; 33:1-9.</p><p>Cleg D., Reda D., Mejias E. et al. Comparison of sulfasalasin and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthr Rheum 1996; 39(12): 2013-20.</p><p>Willkens R., Williams H., Ward J. et al. Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthr Rheum 1984; 27(4): 376-84.</p><p>Kaltwasser J., Nash P., Gladman D. et al. Efficacy and safety of leflunomide in the treat- ment of psoriatic arthritis and psoriasis: a multi- national, double-blind, randomized placebo controlled clinical trial. Arthr Rheum 2004; 50(6): 1939-50.</p><p>Kyle S., Chandler D., Griffiths C.E. et al. Guideline for anti-TNF-а in psoriatic arthritis. Rheumatology 2005; 44: 390-7.</p><p>Tukriewicz A., Moreland L.. Psoriatic Arthritis. Current Concepts on Pathogenesis-Oriented Therapeutic Options. Arthr Rheum 2007; 56(4): 1051-66.</p><p>Sattar N., Crompton Ph., Cherry L. et al. Effects of Tumor Necrosis Factor Blocade on Cardiovascular Risk Factor in Psoriatic arthritis. A double-blind, placebo-controlled Study. Arthr Rheum 2007; 56(3): 831-9.</p><p>Canete J., Pablos J., Sanmarti R. et al. Antiangiogenic Effects of Anti-Tumor Necrosis Factor а Therapy With Infliximab in Psoriatic arthritis. Arthr Rheum 2004; 50(5): 1636-41.</p><p>Cordiali-Fei P., Trento E., D'Agosto G. et al. Effective therapy with anti-TNF-alpha in psori-atic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions. Ann N Y Acad Sci 2007 Sep; 1110: 578-89.</p><p>Antoni C., Kavanaugh A., Kirkhan B. et al. Sustained benefits of infliximab therapy for der-matological and articular manifiestations of pso-riatic arthritis: results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). Arthr Rheum 2005; 52: 1227-36.</p><p>Antoni C., Krueger G.G., de Vlam K. et al. IMPACT 2 Trial Investigators. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 Trial. Ann Rheum Dis 2005; 64: 1150-57.</p><p>Mease P., Gladman D., Ritchlin C. et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis. Arthr Rheum 2005; 52(10): 3279-89.</p><p>Gladman D., Mease P., Rithlin Ch. et al. Adalimumab imroves joint-and skin-related functional impairement in patients with psoriatic arthritis: Patients-reported outcomes of the Adalimumab Effectivness in psoriatic arthritis trials (ADEPT). Ann Rheum Dis 2006; 9: 1-6.</p><p>Gladman D., Mease P., Rithlin Ch. et al. Adalimumab for Long-Term Treatment of Psoriatic Arthritis. Forty-Eight Wek Data From the Adalimumab Effectiveness in Psoriatic ArthritisTrial. Arthr Rheum 2007; 56(2): 476-88.</p></div><br />


Для цитирования:


Коротаева Т.В. Современные возможности терапии псориатического артрита. Современная ревматология. 2008;2(2):13-19. https://doi.org/10.14412/1996-7012-2008-468

For citation:


Korotaeva T.V. Sovremennye vozmozhnosti terapii psoriaticheskogo artrita. Modern Rheumatology Journal. 2008;2(2):13-19. (In Russ.) https://doi.org/10.14412/1996-7012-2008-468

Просмотров: 510


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)